Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi Arabia

BACKGROUND AND OBJECTIVES: Data regarding the safety and efficacy of antiviral therapy with pegylated interferon (PEG-IFN) and ribavirin (RBV) in patients with sickle-cell disease (SCD) and hepatitis C virus (HCV) infection are scanty. In this study, our aim was to evaluate the safety and efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Agha, Adnan, Chakik, Rafaat, Abdulhadi Ali, Mamdouh M., Alsaudi, Dib, Sammito, Giorgio, Giannini, Edoardo Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2013
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074907/
https://www.ncbi.nlm.nih.gov/pubmed/24413867
http://dx.doi.org/10.5144/0256-4947.2013.610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074907/
https://www.ncbi.nlm.nih.gov/pubmed/24413867
http://dx.doi.org/10.5144/0256-4947.2013.610

Ejemplares similares